
Industry Leading
Pure peptides. Backed by science.
Pure. Tested. Trusted. Method Peptides delivers ≥99% purity peptides in sterile vials, free from contaminants.
Shop PeptidesWhat are Peptides?

Peptides
Short chains. Big impact.
Peptides are short chains of amino acids that act as signaling molecules, supporting processes like tissue repair, hormone regulation, and inflammation control.
By leveraging targeted research compounds, many users seek improvements in recovery, composition, and overall vitality.
Peptides are like tiny proteins your body uses as “messages.” They travel in the bloodstream and click into matching receptors on cells. Think of it like a key fitting a lock. When they connect, they tell the cell what to do: start repairing tissue, release or balance certain hormones, or cool down inflammation. Each peptide sends a specific message, so the effects are targeted. A common example is GLP-1, which helps signal fullness and supports steady blood sugar.

GLP-3
Retatrutide 12mg
In stock
Retatrutide is a next-generation multi-agonist peptide (GLP-1/GIP/glucagon) designed to support weight management, appetite regulation, and improved metabolic health. Its unique triple action makes it one of the most advanced options for fat loss and overall wellness.
- ≥99% purity (COA)
- Adulterant-free & sterile
- Trusted research sources
For research use only.
From the Research Hub

GHK-Cu: The Peptide Complex Researchers Are Exploring
GHK-Cu is a copper peptide complex studied for its roles in skin, hair, and tissue biology. This guide explains why it has become an important focus in regenerative research.

Retatrutide: The Triple Agonist Researchers Are Exploring
Retatrutide is a triple receptor agonist studied for its effects on GLP-1, GIP, and glucagon pathways. This guide exp...

Tirzepatide: Dual Receptor Research Explained
Tirzepatide is a dual receptor agonist studied for its impact on GLP-1 and GIP pathways. This beginner’s guide explor...

Semaglutide: How Researchers Study GLP-1 Pathways
Semaglutide is a GLP-1 receptor agonist studied in metabolic science. This guide explains its role in glucose regulat...
Backed by Research — GLP-1
Peer-reviewed studies in adults with overweight or obesity


Semaglutide (STEP 1): Once-weekly 2.4 mg plus lifestyle support produced clinically meaningful weight loss over 68 weeks in adults with overweight or obesity.
Tirzepatide (SURMOUNT-1): 72-week trial showed substantial, sustained weight reduction with once-weekly 5/10/15 mg in adults with obesity without diabetes.
Retatrutide (Phase 2): Once-weekly triple-hormone receptor agonist produced dose-dependent weight reductions over 24–48 weeks in adults with obesity.
For educational purposes only. Not medical advice. Prescription medicines are not intended to diagnose, treat, cure, or prevent any disease.